Related Experiment Video
Updated: May 9, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
[Research advances of the biliary and nonbiliary pathways to reverse cholesterol transport]
Jia-Lin Wang1, Yan-Yan Tang, Jie Wu
1Key Laboratory for Atherosclerology of Hunan Province, Life Science Research Center, University of South China, Hengyang 421001, China.
Abstract:
Plasma cholesterol levels are the major risk factor for atherosclerosis (AS) and coronary heart disease (CHD). Biliary pathway to reverse cholesterol transport (RCT) is the process that cholesterol in peripheral tissue and macrophages is transported to liver by lipoprotion, then secreted into the bile and finally excreted through feces. According to a large number of studies, there is nonbiliary pathway to RCT to clear excess cholesterol in the body, apart from the biliary pathway to RCT. This review focuses on the current views on the different pathways to RCT, and the regulation on the RCT of the relevant transports, lipoprotion, receptor and so on, aiming at providing new theoretical evidence and acting targets for the treatment of cholelithiasis and AS related disease.
Related Concept Videos
Hepatic Drug Clearance: Role of Transporters
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Hepatic Drug Excretion: Influencing Factors

